MedTrace Logo

Development of an Exoskeleton for Patients' Mobility.

NCT06513390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-07-22

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the performance of a state-of-the-art adaptive CPG-based exoskeleton control system (intelligent mode) under a multi-metric analysis (involving three-dimensional gait analysis, muscle activity, oxygen consumption, user comfort, and exoskeleton performance scores) and comparing it to a standard commercial exoskeleton control system (default mode)

The main question it aims to answer is: Could the adaptive version improve natural walking and essential lower limb motions?

Participants will:

All participants were assigned into two groups to receive an alternate sequence of walking with the intelligent mode or the default mode of the lower-limb exoskeleton Exo-H3 at high and normal speed.

Conditions

  • Healthy

Interventions

DEVICE

Exoskeleton of default mode

Default mode: A standard control system offering a conventional assistive function of Exo-H3.

DEVICE

Exoskeleton of Intelligent mode

Intelligent mode: The adaptive CPG-based control system developed by our researchers from Exo-H3.

Sponsors & Collaborators

  • Vidyasirimedhi Institute of Science & Technology (VISTEC)

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-07-12
Completion
2022-07-12

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06513390 on ClinicalTrials.gov